Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024103451> ?p ?o ?g. }
- W2024103451 endingPage "e79" @default.
- W2024103451 startingPage "e79" @default.
- W2024103451 abstract "The IRE1α-XBP1 pathway, a key component of the endoplasmic reticulum (ER) stress response, is considered to be a critical regulator for survival of multiple myeloma (MM) cells. Therefore, the availability of small-molecule inhibitors targeting this pathway would offer a new chemotherapeutic strategy for MM. Here, we screened small-molecule inhibitors of ER stress-induced XBP1 activation, and identified toyocamycin from a culture broth of an Actinomycete strain. Toyocamycin was shown to suppress thapsigargin-, tunicamycin- and 2-deoxyglucose-induced XBP1 mRNA splicing in HeLa cells without affecting activating transcription factor 6 (ATF6) and PKR-like ER kinase (PERK) activation. Furthermore, although toyocamycin was unable to inhibit IRE1α phosphorylation, it prevented IRE1α-induced XBP1 mRNA cleavage in vitro. Thus, toyocamycin is an inhibitor of IRE1α-induced XBP1 mRNA cleavage. Toyocamycin inhibited not only ER stress-induced but also constitutive activation of XBP1 expression in MM lines as well as primary samples from patients. It showed synergistic effects with bortezomib, and induced apoptosis of MM cells including bortezomib-resistant cells at nanomolar levels in a dose-dependent manner. It also inhibited growth of xenografts in an in vivo model of human MM. Taken together, our results suggest toyocamycin as a lead compound for developing anti-MM therapy and XBP1 as an appropriate molecular target for anti-MM therapy." @default.
- W2024103451 created "2016-06-24" @default.
- W2024103451 creator A5000708721 @default.
- W2024103451 creator A5004600619 @default.
- W2024103451 creator A5005753111 @default.
- W2024103451 creator A5014486708 @default.
- W2024103451 creator A5015338865 @default.
- W2024103451 creator A5017360616 @default.
- W2024103451 creator A5018501206 @default.
- W2024103451 creator A5020123177 @default.
- W2024103451 creator A5037229306 @default.
- W2024103451 creator A5038817476 @default.
- W2024103451 creator A5044499778 @default.
- W2024103451 creator A5048020501 @default.
- W2024103451 creator A5057002240 @default.
- W2024103451 creator A5057302383 @default.
- W2024103451 creator A5071767196 @default.
- W2024103451 creator A5073391500 @default.
- W2024103451 creator A5076711317 @default.
- W2024103451 creator A5078852881 @default.
- W2024103451 date "2012-07-20" @default.
- W2024103451 modified "2023-10-18" @default.
- W2024103451 title "Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing" @default.
- W2024103451 cites W1546139069 @default.
- W2024103451 cites W1672219033 @default.
- W2024103451 cites W1965843055 @default.
- W2024103451 cites W1970090817 @default.
- W2024103451 cites W1970854602 @default.
- W2024103451 cites W1986290768 @default.
- W2024103451 cites W1987841739 @default.
- W2024103451 cites W1988482079 @default.
- W2024103451 cites W1989573227 @default.
- W2024103451 cites W1990136127 @default.
- W2024103451 cites W1995706536 @default.
- W2024103451 cites W2012345849 @default.
- W2024103451 cites W2013253148 @default.
- W2024103451 cites W2016138759 @default.
- W2024103451 cites W2017937681 @default.
- W2024103451 cites W2020917396 @default.
- W2024103451 cites W2023007035 @default.
- W2024103451 cites W2032584297 @default.
- W2024103451 cites W2039379491 @default.
- W2024103451 cites W2040651817 @default.
- W2024103451 cites W2042294920 @default.
- W2024103451 cites W2045242604 @default.
- W2024103451 cites W2050260607 @default.
- W2024103451 cites W2055789616 @default.
- W2024103451 cites W2071273959 @default.
- W2024103451 cites W2072714194 @default.
- W2024103451 cites W2076451697 @default.
- W2024103451 cites W2081294646 @default.
- W2024103451 cites W2084944302 @default.
- W2024103451 cites W2088081193 @default.
- W2024103451 cites W2088948324 @default.
- W2024103451 cites W2089273088 @default.
- W2024103451 cites W2106314483 @default.
- W2024103451 cites W2117672191 @default.
- W2024103451 cites W2120736516 @default.
- W2024103451 cites W2127419185 @default.
- W2024103451 cites W2127639686 @default.
- W2024103451 cites W2127848114 @default.
- W2024103451 cites W2127906377 @default.
- W2024103451 cites W2140974913 @default.
- W2024103451 cites W2144065739 @default.
- W2024103451 cites W2153442636 @default.
- W2024103451 cites W2158414356 @default.
- W2024103451 cites W2159466552 @default.
- W2024103451 cites W2167095297 @default.
- W2024103451 cites W2169031518 @default.
- W2024103451 cites W2192080449 @default.
- W2024103451 doi "https://doi.org/10.1038/bcj.2012.26" @default.
- W2024103451 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3408640" @default.
- W2024103451 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22852048" @default.
- W2024103451 hasPublicationYear "2012" @default.
- W2024103451 type Work @default.
- W2024103451 sameAs 2024103451 @default.
- W2024103451 citedByCount "140" @default.
- W2024103451 countsByYear W20241034512013 @default.
- W2024103451 countsByYear W20241034512014 @default.
- W2024103451 countsByYear W20241034512015 @default.
- W2024103451 countsByYear W20241034512016 @default.
- W2024103451 countsByYear W20241034512017 @default.
- W2024103451 countsByYear W20241034512018 @default.
- W2024103451 countsByYear W20241034512019 @default.
- W2024103451 countsByYear W20241034512020 @default.
- W2024103451 countsByYear W20241034512021 @default.
- W2024103451 countsByYear W20241034512022 @default.
- W2024103451 countsByYear W20241034512023 @default.
- W2024103451 crossrefType "journal-article" @default.
- W2024103451 hasAuthorship W2024103451A5000708721 @default.
- W2024103451 hasAuthorship W2024103451A5004600619 @default.
- W2024103451 hasAuthorship W2024103451A5005753111 @default.
- W2024103451 hasAuthorship W2024103451A5014486708 @default.
- W2024103451 hasAuthorship W2024103451A5015338865 @default.
- W2024103451 hasAuthorship W2024103451A5017360616 @default.
- W2024103451 hasAuthorship W2024103451A5018501206 @default.
- W2024103451 hasAuthorship W2024103451A5020123177 @default.
- W2024103451 hasAuthorship W2024103451A5037229306 @default.